Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial
Wei Wu(Anhui Agricultural University), Jieqiong Liu(Sun Yat-sen University), Yan Nie(Sun Yat-sen University), Jiewen Chen(Sun Yat-sen University), Yandan Yao(Sun Yat-sen University), Zhanghai He(Sun Yat-sen University), Fengxi Su(Sun Yat-sen University), Liang Jin(Kunming Medical University), Nanyan Rao(Sun Yat-sen University), Heran Deng(Sun Yat-sen University), Yaping Yang(Sun Yat-sen University)
Cited by 14
Related Papers
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
|Molecular Cancer|2011|700
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
|Clinical Cancer Research|2009|435
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
|Oncogene|2011|248
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer
|Cell Research|2017|225
The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis
|Nature Communications|2021|196